Down syndrome blood testing - patau syndrome blood testing - Ninalia NIPT

NIPT by Biomnis The new prenatal trisomy screening test based on maternal blood sample

Trisomy 13

Download the brochure

Down Syndrome blood testing

Non-Invasive Down Syndrome Blood Testing For At-risk Pregnant Women

Pregnant women at high risk of fetal chromosomal disorders including Down Syndrome and Patau Sydrome should ensure they receive screenings from the first trimester. As an alternative to invasive trisomy screening methods such as amniocentesis, EurofinsBiomnis offers Down Syndrome blood testing that is entirely non-invasive, offering expectant parents genuine peace of mind. This NIPT (non-invasive prenatal testing) procedure draws from a simple maternal blood sample, and offers an accuracy rate of over 99%. By choosing a non-invasive Down Syndrome blood testing method, it can be easily and safely determined whether risk of fetal defects is high or low, potentially avoiding amniocentesis procedures which carry a risk of losing the fetus.

While Down Syndrome gets more attention in the media as a relatively common fetal disorder, it's equally important for pregnant women to schedule Patau Syndrome blood testing, in order to rule out risks for the syndrome also known as trisomy 13. Non-invasive trisomy 13 tests are now available, allowing expectant parents to undergo Patau Syndrome blood testing, while eliminating the risks associated with traditional, invasive testing methods. Safe, reliable, and rapid, NIPT tests that assess risk for Patau Syndrome can be obtained starting in only the tenth week of pregnancy. Edward's Syndrome (Trisomy 18) screening is included, as is testing for Down Syndrome. One easy test can offer much reassurance.

To rule out common pregnancy risks, scheduling an NIPT procedure with a primary care physician or other healthcare provider offers patients a safe alternative to invasive tests, including for Edwards' syndrome (trisomy 18). The ground-breaking
screening methods include Edwards' Syndrome blood testing kits that can be ordered to your physician's practice and carried out there, or at a Eurofins Biomnis partner laboratory. During your consultation, your healthcare provider will prescribe an NIPT and ask you to sign an informed consent form, which is mandatory for all genetic tests. The Edwards' Syndrome blood testing procedure is quick, and results for the trisomy 18 screening test are generally available after 7 days.

Advantages of NIPT by Biomnis

> 99 % Detection rateof NIPT test 1 Single blood sample 10 Available from week 10of amenorrhoea 7 Results availablewithin 7 working days 95 % Can minimize unnecessary invasive sampling by 95%